Study to Assess Efficacy & Safety of Reparixin in Pancreatic Islet Transplantation
Clinical trial NCT01817959 · COMPLETED
Trial details
- NCT number
- NCT01817959
- Sponsor
- Dompé Farmaceutici S.p.A
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2016-12-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.